top of page


Resources


NEWS
BLOG

Top 5 Things We Learned at ASCO 2026: Why the Future of Oncology Runs on Structured Pathology Data
ASCO 2026 made it crystal clear that the next wave of innovation in oncology will be won or lost on one thing – whether we can turn rich pathology and biomarker findings into structured, computable data that actually flows into AI, trials, and clinical decision‑making at scale.
OUR CASE STUDIES
View detailed reports demonstrating mTuitive's impact on hospitals around the world, covering benefits like ROI, automation and reduced reporting time and costs. Including:
PIH Good Samaritan Hospital
Cambridge Memorial Hospital
London Health Sciences Centre
OUR CASE STUDIES
NEWSLETTER
mTuitive's monthly newsletter covers industry news and mTuitive product and content updates.


bottom of page